Digital Story of the Week
The US company behind ChatGPT has announced its first international office will be based in London. Chloe Smith, the Science, Innovation and Technology Secretary, told the BBC ‘Open Ai’s decision to expand into London as their first international office is another vote of confidence for Britain as an AI powerhouse and, in OpenAI’s own words, for our vibrant technology ecosystem and exceptional talent.’
Partnership Story of the Week
The third and final season of the AppleTV+ football themed Ted Lasso has generated £18.4m in UK and US net sponsorship value according to research from YouGov. The latest season of the hit comedy drama has received 172 million views since its release a month ago, driving a total net sponsorship value of £47.3m for all brands on the show, with £32.2m attributed to team clothing.
Radio Story of the Week
Joanna Gosling is joining Classic FM to host a new Sunday programme, 1pm-4pm from this weekend. This marks a return to radio for the presenter, journalist and writer who started as a reporter in local radio before moving to Independent Radio News. Joanna, a highly respected broadcast journalist, has spent more than 20 years as a presenter and anchor for BBC News. Phillip Noyce, Classic FM’s managing editor said, ‘A trusted, friendly voice and known to millions through television news, we look forward to her becoming part of the Classic Fm family.’
Industry Story of the Week
The Incorporated Society of British Advertisers (ISBA) has launched the fourth test phase of its cross-media measurement tool Origin. In the latest phase, Origin will be testing its Virtual ID Model which will identify and correct the demographic reach of ad campaigns. The project began in 2021 and is designed for advertisers to plan, track and evaluate campaigns across broadcast television and digital media platforms. It does this by providing a single source dataset of the reach of campaigns across these platforms. EE, L’Oreal, Pepsico, Unilever and Procter and Gamble are the five major brands to participate in the fourth phase of the trial.
